Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linong Ji

Showing results (461-470 of 588) with videos related to

Pageof 59
Sort By:
Diabetes, Obesity & Metabolism|September 29, 2020
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspectiveLinong Ji, Juliana C N Chan, Miao Yu, et al.
Diabetes Technology & Therapeutics|July 15, 2015
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline CharacteristicsLinong Ji, Puhong Zhang, Jianping Weng, et al.
Contemporary Clinical Trials|November 19, 2025
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trialYingying Luo, Hongwei Jiang, Bimin Shi, et al.
Journal of Diabetes|April 25, 2020
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT)Leili Gao, Puhong Zhang, Jianping Weng, et al.
Diabetes Research and Clinical Practice|May 17, 2023
Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes managementAlice P S Kong, Soo Lim, Seung-Hyun Yoo, et al.
Advances in Therapy|March 24, 2026
Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature ReviewYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.
Diabetes|December 10, 2020
Low-Frequency Genetic Variant in the Hepatic Glucokinase Gene Is Associated With Type 2 Diabetes and Insulin Resistance in Chinese PopulationYumin Ma, Yingying Luo, Siqian Gong, et al.
JAMA Network Open|March 3, 2025
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical TrialLinong Ji, Jianhua Ma, Yujin Ma, et al.
Diabetologia|September 10, 2025
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global CouncilFrancesco Giorgino, Fawaz Alzaid, Anca Pantea Stoian, et al.
Diabetes, Obesity & Metabolism|January 3, 2023
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trialLinong Ji, Xiaozhen Jiang, Qingshun Hao, et al.
Pageof 59

Showing results (461-470 of 588) with videos related to

Sort By:
Pageof 59
Diabetes, Obesity & Metabolism|September 29, 2020
Early combination versus initial metformin monotherapy in the management of newly diagnosed type 2 diabetes: An East Asian perspectiveLinong Ji, Juliana C N Chan, Miao Yu, et al.
Diabetes Technology & Therapeutics|July 15, 2015
Observational Registry of Basal Insulin Treatment (ORBIT) in Patients with Type 2 Diabetes Uncontrolled by Oral Hypoglycemic Agents in China--Study Design and Baseline CharacteristicsLinong Ji, Puhong Zhang, Jianping Weng, et al.
Contemporary Clinical Trials|November 19, 2025
Mazdutide versus Semaglutide for the treatment of type 2 diabetes and obesity: Rationale, design and baseline data of DREAMS-3 phase 3 trialYingying Luo, Hongwei Jiang, Bimin Shi, et al.
Journal of Diabetes|April 25, 2020
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT)Leili Gao, Puhong Zhang, Jianping Weng, et al.
Diabetes Research and Clinical Practice|May 17, 2023
Asia-Pacific consensus recommendations for application of continuous glucose monitoring in diabetes managementAlice P S Kong, Soo Lim, Seung-Hyun Yoo, et al.
Advances in Therapy|March 24, 2026
Evidence-Based Positioning of Sodium-Glucose Co-transporter 2 Inhibitors and Glucagon-Like Peptide 1 Receptor Agonists in the Management of Chronic Kidney Disease with Type 2 Diabetes and Overweight or Obesity: A Systematic Literature ReviewYehuda Handelsman, Alice Y Y Cheng, Gian Paolo Fadini, et al.
Diabetes|December 10, 2020
Low-Frequency Genetic Variant in the Hepatic Glucokinase Gene Is Associated With Type 2 Diabetes and Insulin Resistance in Chinese PopulationYumin Ma, Yingying Luo, Siqian Gong, et al.
JAMA Network Open|March 3, 2025
Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes: A Randomized Clinical TrialLinong Ji, Jianhua Ma, Yujin Ma, et al.
Diabetologia|September 10, 2025
Global challenges in diabetes research and care: which way forward? An appraisal from the EASD Global CouncilFrancesco Giorgino, Fawaz Alzaid, Anca Pantea Stoian, et al.
Diabetes, Obesity & Metabolism|January 3, 2023
Efficacy and safety of janagliflozin monotherapy in Chinese patients with type 2 diabetes mellitus inadequately controlled on diet and exercise: A multicentre, randomized, double-blind, placebo-controlled, Phase 3 trialLinong Ji, Xiaozhen Jiang, Qingshun Hao, et al.
Pageof 59